|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
1 months to Dec 31, 2022
|
FY2021
9 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash Flows From Operating Activities: | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash used in operating activities: | |||||
| Impairment of goodwill | |||||
| Impairment of in-process research and development | |||||
| Stock-based compensation | |||||
| Issuance of common stock pursuant to vendor agreements | |||||
| Shares issued as consideration for extension of lock-up period | |||||
| Write-off of deferred offering costs | |||||
| Depreciation of fixed assets | |||||
| Non-cash rent expense | |||||
| Deferred tax (benefit) provision | |||||
| Changes in operating assets and liabilities: | |||||
| Prepaid expenses and other current assets | |||||
| Deferred offering costs | |||||
| Accounts payable | |||||
| Vendor deposits | |||||
| Operating lease liability | |||||
| Accrued expenses and other current liabilities | |||||
| Net Cash Used In Operating Activities | |||||
| Cash Flows From Financing Activities: | |||||
| Proceeds from issuance of common stock in public offering | |||||
| Registration and issuance costs associated with common stock issuance | |||||
| Redemption of Series A Preferred Stock | |||||
| Proceeds from issuance of preferred stock in private placement | |||||
| Purchase of treasury stock | |||||
| Private placement of warrants | |||||
| Warrant inducement offer - exercise proceeds | |||||
| Exercise of pre-funded warrants | |||||
| Payment of offering costs | |||||
| At the market issuance of stock proceeds | |||||
| Registration and issuance costs associated with preferred stock issuance | |||||
| Registration and issuance costs associated with warrant issuance | |||||
| Net Cash Provided By Financing Activities | |||||
| Net Decrease in Cash | |||||
| Cash - Beginning of Period | |||||
| Total cash - Beginning of Period | |||||
| Cash - End of Period | |||||
| Total cash - End of Period | |||||
| Non-cash investing and financing activities: | |||||
| Reclassification of formerly redeemable common stock | |||||
| Accounts payable for deferred offering costs | |||||
| Warrant modification - incremental value | |||||
| Warrant modifications - incremental value | |||||
| Warrant inducement offer - incremental value | |||||
| Accounts payable and accrued expenses for offering costs | |||||
Loading...